Days later, Bloomberg reported that Danaher Corp. was no longer considering a takeover of Catalent, according to people familiar with the situation. Danaher had earlier made overtures to the ...

Days later, Danaher Corp. was no longer considering a takeover offer, according to a Bloomberg report citing people familiar with the situation. Danaher had earlier made overtures to Catalent valuing ...

Catalent Inc. shares rose after the troubled contract drug manufacturer gave investors some reassurance about a slashed ...

Analysts say the events over the past weeks may have hurt takeover interest in Catalent. Danaher Corp. shelved a potential offer in April, after earlier making overtures that valued the company at a ...

WASHINGTON, May 9, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common ...

A whale with a lot of money to spend has taken a noticeably bearish stance on Danaher. Looking at options history for Danaher DHR we detected 10 strange trades. If we consider the specifics of ...

Catalent is a partner for pharmaceutical and biotechnology companies, helping its customers to bring products to the market in a faster fashion. The company does this by providing oral, injectable ...

BOULDER, Colo., May 17, 2023 /PRNewswire/ -- Danaher Cryogenics, a leader in manufacturing fully-integrated sub-Kelvin cryostats and engineering elegant cryogenic solutions, today announced the ...

BOULDER, Colo., May 17, 2023 /PRNewswire/ -- Danaher Cryogenics, a leader in manufacturing fully-integrated sub-Kelvin cryostats and engineering elegant cryogenic solutions, today announced the ...